Literature DB >> 2019253

In vivo regulation of parathyroid hormone-related peptide messenger ribonucleic acid in the rat uterus by 17 beta-estradiol.

M A Thiede1, S C Harm, D M Hasson, R M Gardner.   

Abstract

During pregnancy, elevated levels of PTH-related peptide (PTHrP) persist in the myometrium of the rat uterus. Near term, intrauterine occupancy is correlated with high levels of PTHrP messenger RNA in the gravid horn of the unilaterally pregnant uterus. In nongravid tissue from these same animals the presence of smaller yet significant elevations of PTHrP mRNA suggests that the PTHrP gene also may be regulated by humoral factor(s). To test this hypothesis, we assessed the action of 17 beta-estradiol (E2) on the expression of the PTHrP gene in the uterus of the ovariectomized rat. While low levels of PTHrP mRNA are detected in uteri from ovariectomized rats, a single dose of E2 (4, 40, or 400 micrograms/kg body weight) stimulated a 6- to 8-fold increase in the levels of PTHrP mRNA in the uterus at approximately 2 h after E2 treatment. This increase was transient with levels gradually declining to pretreatment (basal) levels within 24 h. Other steroid hormones tested, including dihydrotestosterone, dexamethasone, and progesterone, failed to stimulate this response. The increase of PTHrP mRNA accumulation required a dose greater than 0.4 micrograms/kg. The magnitude and duration of PTHrP mRNA accumulation were very similar when doses of 40 or 400 micrograms/kg were used. In addition, the stimulation of the PTHrP gene by E2 is neither age dependent nor specific to the rat and is, in part, under transcriptional control. Together, these data indicate that in vivo E2 regulates the levels of PTHrP mRNA in the rat uterus and support a role for E2 in the increased expression of PTHrP mRNA in early gestational tissue, as well as in the nongravid horn of the unilaterally pregnant uterus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2019253     DOI: 10.1210/endo-128-5-2317

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  PTHrP gene expression in cancer: do all paths lead to Ets?

Authors:  Virgile Richard; Thomas J Rosol; John Foley
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2005       Impact factor: 1.807

2.  Effect of parathyroid hormone related protein, and dihydrotestosterone on proliferation and ornithine decarboxylase mRNA in human prostate cancer cell lines.

Authors:  F Asadi; M Faraj; S Malakouti; S C Kukreja
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  Regulated expression of matrix metalloproteinases, inflammatory mediators, and endometrial matrix remodeling by 17beta-estradiol in the immature rat uterus.

Authors:  Louise A Russo; Bryan J Peano; Shreya P Trivedi; Todd D Cavalcanto; Benjamin A Olenchock; Joseph A Caruso; Amanda R Smolock; Oleg Vishnevsky; Russell M Gardner
Journal:  Reprod Biol Endocrinol       Date:  2009-11-04       Impact factor: 5.211

4.  Endotoxin increases parathyroid hormone-related protein mRNA levels in mouse spleen. Mediation by tumor necrosis factor.

Authors:  J L Funk; E J Krul; A H Moser; J K Shigenaga; G J Strewler; C Grunfeld; K R Feingold
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

5.  Expression of parathyroid hormone-related protein in the rat glomerulus and tubule during recovery from renal ischemia.

Authors:  N E Soifer; S K Van Why; M B Ganz; M Kashgarian; N J Siegel; A F Stewart
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

6.  Parathyroid hormone-related protein secretion is inhibited by oestradiol and stimulated by antioestrogens in KPL-3C human breast cancer cells.

Authors:  J Kurebayashi; H Sonoo
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Hypercalcemia in pregnancy - a multifaceted challenge: case reports and literature review.

Authors:  Evelyne Rey; Claude-Emilie Jacob; Maral Koolian; Francine Morin
Journal:  Clin Case Rep       Date:  2016-09-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.